The application of VCP inhibitors abrogated the inhibition of NIS function mediated by VCP and increased NIS expression at the plasma membrane followed by increased RAI uptake in thyroid cancer cells and primary thyrocytes isolated from a mouse model. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.